Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
Ermias A MekonnenWondwossen G TekleSohum K DesaiAmeer E HassanPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2022)
Intracranial atherosclerotic disease (ICAD) is a common cause of acute ischemic stroke. ICAD has a high rate of recurrent ischemic stroke despite recommended adequate medical treatment. Endovascular treatment of ICAD has been controversial due to high periprocedural complication in historic randomized clinical trials (RCTs). Recently, a multicenter prospective study of stent placement in patients with high grade intracranial stenosis that evaluated safety and efficacy of Balloon-mounted stents (BMS) in symptomatic ICAD showed low rates of periprocedural stroke (5.6%) than the SAMMPRIS (14.7%) and VISSIT (21.4%) trials. This review highlights the recent evolution of endovascular therapy for symptomatic ICAD.
Keyphrases
- acute ischemic stroke
- endovascular treatment
- high grade
- atrial fibrillation
- percutaneous coronary intervention
- optic nerve
- direct oral anticoagulants
- low grade
- catheter ablation
- antiplatelet therapy
- cross sectional
- clinical trial
- coronary artery disease
- double blind
- venous thromboembolism
- acute coronary syndrome
- brain injury
- blood brain barrier
- aortic dissection